Phase i single ascending dose study. TO7. Nida pharmacokinetic analysis resource center. 09/10/2024 - 03/09/2026. Nida REF. No. N01DA-19-8947.
Active Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Technical Resources International, Inc. UEI FAA2LVENETH4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $415,717
Award facts
- Opportunity
-
- 75N95024F00001 Solicitation number
- Contract value 100% obligated
- $415,717.00 Current and potential, with all options
- Completion date 85% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Westlake, MD 20817, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Change Order | $33,883 | |
| Original award | $381,834 |
About this award
The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $415,717 to Technical Resources International, Inc. (TRI), a minority-owned and woman-owned small business based in Bethesda, Maryland, for a Phase I Single Ascending Dose Study under the Pharmacokinetic Analysis Resource Center program. The contract, awarded on September 10, 2024, with an ultimate completion date of March 8, 2027, represents a cost-plus-fixed-fee engagement. This delivery order was issued under NIDA's existing $2.5 million Indefinite Delivery Vehicle (IDV) for pharmacokinetic analysis services, which enables flexible and rapid procurement capabilities across NIDA's research programs. No set-aside designation was applied to this award, indicating TRI's competitive selection in an open competition.
The work will be performed in Westlake, Maryland and falls within NIDA's broader mission to support critical drug abuse and addiction research. TRI brings substantial expertise in clinical research support, having established itself as a key contractor across multiple national health institutes including the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and other federal health agencies. The contractor's background encompasses clinical trial execution, regulatory affairs, data management, and specialized scientific services. A no-cost extension was subsequently approved, extending the performance period to March 8, 2027, allowing for continued support of NIDA's pharmacokinetic research initiatives without additional budget impact.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Technical Resources International, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 10, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $415,717 on 75N95024F00001.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95019D00009, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award